Last Updated: June 17, 2026

POKONZA Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Pokonza, and when can generic versions of Pokonza launch?

Pokonza is a drug marketed by Genus and Genus Lifesciences and is included in two NDAs.

The generic ingredient in POKONZA is potassium chloride. There are two hundred and forty drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pokonza

A generic version of POKONZA was approved as potassium chloride by ACTAVIS LABS FL INC on April 10^th, 2002.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for POKONZA?
What are the global sales for POKONZA?
What is Average Wholesale Price for POKONZA?

Summary for POKONZA

US Patents:	0
Applicants:	2
NDAs:	2

US Patents and Regulatory Information for POKONZA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Genus	POKONZA	potassium chloride	FOR SOLUTION;ORAL	208019-002	Aug 25, 2023		RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Genus	POKONZA	potassium chloride	FOR SOLUTION;ORAL	208019-004	Nov 12, 2025		RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Genus Lifesciences	POKONZA	potassium chloride	SOLUTION;ORAL	206814-003	Nov 25, 2025		RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.